Kristin Yarema
CIK 1803794 · Chief Executive Officer · last filed 2026-03-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.26M
Companies
3
Total Filings
11
Lifetime Open-Market Net
$489.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMA | Chief Executive Officer | 85,400 | $5.62 | $479.9K | $0 | 2 | 2026-03-18 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | President and CEO | 0 | $9.50 | $0 | $0 | 3 | 2025-01-08 |
| ATRA | Chief Commercial Officer | 171,415 | $10.41 | $1.78M | $489.3K | 6 | 2022-03-03 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.